Progress in bioreactors of bioartificial livers

Hepatobiliary and Pancreatic Diseases International

Volumn 8, Issue 2, 2009, Pages 134-140

  Yu, Cheng Bo ^a   Pan, Xiao Ping ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bioartificial liver; Bioreactor; Hepatocyte; Liver failure

Indexed keywords

AMC BAL BIOREACTOR; BIOARTIFICIAL LIVER; BIOREACTOR; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CLINICAL TRIAL; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER SUPPORT; LIVER TRANSPLANTATION; MELS BAL BIOREACTOR; MICROFIBRABRICATED GROOVE BIOREACTOR; MICROFLUIDIC ANALYSIS; MICROFLUIDIC POLYDIMETHYLSILOXANE BIOREACTOR; REVIEW; SLIDE BIOREACTOR;

BIOREACTORS; HUMANS; LIVER FAILURE; LIVER, ARTIFICIAL;

EID: 64949196687     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Millis JM, Losanoff JE. Technology insight: liver support systems. Nat Clin Pract Gastroenterol Hepatol 2005;2:398-405; quiz 434.
2. Li LJ, Yang Q, Huang JR, Xu XW, Chen YM, Fu SZ. Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases. World J Gastroenterol 2004;10:2984-2988.
3. Du WB, Li LJ, Huang JR, Yang Q, Liu XL, Li J, et al. Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 2005;37:4359-4364.
4. Yoshiba M, Sekiyama K, Iwamura Y, Sugata F. Development of reliable artificial liver support (ALS)--plasma exchange in combination with hemodiafiltration using high-performance membranes. Dig Dis Sci 1993;38:469-476.
5. Chamuleau RA, Poyck PP, van de Kerkhove MP. Bioartificial liver: its pros and cons. Ther Apher Dial 2006; 10:168-174.
6. Abe T, Kobata H, Hanba Y, Kitabata Y, Narukawa N, Hasegawa H, et al. Study of plasma exchange for liver failure: beneficial and harmful effects. Ther Apher Dial 2004;8:180-184.
7. van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004;240:216-230.
8. Tilles AW, Berthiaume F, Yarmush ML, Tompkins RG, Toner M. Bioengineering of liver assist devices. J Hepatobiliary Pancreat Surg 2002;9:686-696.
9. McLaughlin BE, Tosone CM, Custer LM, Mullon C. Overview of extracorporeal liver support systems and clinical results. Ann N Y Acad Sci 1999;875:310-325.
10. Sauer IM, Obermeyer N, Kardassis D, Theruvath T, Gerlach JC. Development of a hybrid liver support system. Ann N Y Acad Sci 2001;944:308-319.
11. Shito M, Kim NH, Baskaran H, Tilles AW, Tompkins RG, Yarmush ML, et al. In vitro and in vivo evaluation of albumin synthesis rate of porcine hepatocytes in a flat-plate bioreactor. Artif Organs 2001;25:571-578.
12. Shito M, Tilles AW, Tompkins RG, Yarmush ML, Toner M. Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure. J Surg Res 2003;111: 53-62.
13. De Bartolo L, Jarosch-Von Schweder G, Haverich A, Bader A. A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. Biotechnol Prog 2000;16:102-108.
14. Lu HF, Lim WS, Zhang PC, Chia SM, Yu H, Mao HQ, et al. Galactosylated poly(vinylidene difluoride) hollow fiber bioreactor for hepatocyte culture. Tissue Eng 2005;11:1667-1677.
15. Ho Ye S, Watanabe J, Takai M, Iwasaki Y, Ishihara K. High functional hollow fiber membrane modified with phospholipid polymers for a liver assist bioreactor. Biomaterials 2006;27:1955-1962.
16. Sullivan JP, Gordon JE, Palmer AF. Simulation of oxygen carrier mediated oxygen transport to C3A hepatoma cells housed within a hollow fiber bioreactor. Biotechnol Bioeng 2006;93:306-317.
17. Wen F, Chang S, Toh YC, Arooz T, Zhuo L, Teoh SH, et al. Development of dual-compartment perfusion bioreactor for serial coculture of hepatocytes and stellate cells in poly(lactic-co-glycolic acid)-collagen scaffolds. J Biomed Mater Res B Appl Biomater 2008;87:154-162.
18. Chen JP, Lin CT. Dynamic seeding and perfusion culture of hepatocytes with galactosylated vegetable sponge in packed-bed bioreactor. J Biosci Bioeng 2006;102:41-45.
19. Torok E, Vogel C, Lütgehetmann M, Ma PX, Dandri M, Petersen J, et al. Morphological and functional analysis of rat hepatocyte spheroids generated on poly(L-lactic acid) polymer in a pulsatile flow bioreactor. Tissue Eng 2006;12: 1881-1890.
20. Morsiani E, Pazzi P, Puviani AC, Brogli M, Valieri L, Gorini P, et al. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs 2002;25:192-202.
21. Nakazawa K, Ijima H, Fukuda J, Sakiyama R, Yamashita Y, Shimada M, et al. Development of a hybrid artificial liver using polyurethane foam/ hepatocyte spheroid culture in a preclinical pig experiment. Int J Artif Organs 2002;25:51-60.
22. Dixit V, Gitnick G. The bioartificial liver: state-of-the-art. Eur J Surg Suppl 1998;:71-76.
23. Kinasiewicz A, Gautier A, Lewiska D, Smietanka A, Legallais C, Weryński A. Three-dimensional growth of human hepatoma C3A cells within alginate beads for fluidized bioartificial liver. Int J Artif Organs 2008;31:340-347.
24. Murtas S, Capuani G, Dentini M, Manetti C, Masci G, Massimi M, et al. Alginate beads as immobilization matrix for hepatocytes perfused in a bioreactor: a physicochemical characterization. J Biomater Sci Polym Ed 2005; 16:829-846.
25. David B, Doré E, Jaffrin MY, Legallais C. Mass transfers in a fluidized bed bioreactor using alginate beads for a future bioartificial liver. Int J Artif Organs 2004;27:284-293.
26. Gerlach JC, Encke J, Hole O, Müller C, Ryan CJ, Neuhaus P. Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation 1994;58:984-988.
27. Sosef MN, Van De Kerkhove MP, Abrahamse SL, Levi MM, Chamuleau RA, Van Gulik TM. Blood coagulation in anhepatic pigs: effects of treatment with the AMC-bioartificial liver. J Thromb Haemost 2003;1:511-515.
28. van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, et al. Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs 2002;25:950-959.
29. van de Kerkhove MP, Poyck PP, Deurholt T, Hoekstra R, Chamuleau RA, van Gulik TM. Liver support therapy: an overview of the AMC-bioartificial liver research. Dig Surg 2005;22:254-264.
30. Sauer IM, Gerlach JC. Modular extracorporeal liver support. Artif Organs 2002;26:703-706.
31. Pless G, Sauer IM. Bioartificial liver: current status. Transplant Proc 2005;37:3893-3895.
32. Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, et al. Clinical extracorporeal hybrid liver support--phase I study with primary porcine liver cells. Xenotransplantation 2003;10:460-469.
33. Sauer IM, Zeilinger K, Pless G, Kardassis D, Theruvath T, Pascher A, et al. Extracorporeal liver support based on primary human liver cells and albumin dialysis--treatment of a patient with primary graft non-function. J Hepatol 2003;39:649-653.
34. Leclerc E, Sakai Y, Fujii T. Microfluidic PDMS (polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes. Biotechnol Prog 2004;20:750-755.
35. Schwartlander R, Schmid J, Brandenburg B, Katenz E, Vondran FW, Pless G, et al. Continuously microscopically observed and process-controlled cell culture within the SlideReactor: proof of a new concept for cell characterization. Tissue Eng 2007;13:187-196.
36. Sauer IM, Schwartlander R, Schmid J, Efimova E, Vondran FW, Kehr D, et al. The SlideReactor--a simple hollow fiber based bioreactor suitable for light microscopy. Artif Organs 2005;29:264-267.
37. Park J, Berthiaume F, Toner M, Yarmush ML, Tilles AW. Microfabricated grooved substrates as platforms for bioartificial liver reactors. Biotechnol Bioeng 2005;90: 632-644.
38. Kataoka K, Nagao Y, Nukui T, Akiyama I, Tsuru K, Hayakawa S, et al. An organic-inorganic hybrid scaffold for the culture of HepG2 cells in a bioreactor. Biomaterials 2005;26:2509-2516.
39. Hoque ME, Mao HQ, Ramakrishna S. Hybrid braided 3-D scaffold for bioartificial liver assist devices. J Biomater Sci Polym Ed 2007;18:45-58.
40. Chung TW, Yang J, Akaike T, Cho KY, Nah JW, Kim SI, et al. Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment. Biomaterials 2002;23:2827-2834.
41. Li J, Pan J, Zhang L, Guo X, Yu Y. Culture of primary rat hepatocytes within porous chitosan scaffolds. J Biomed Mater Res A 2003;67:938-943.
42. Wang X, Yan Y, Lin F, Xiong Z, Wu R, Zhang R, et al. Preparation and characterization of a collagen/chitosan/heparin matrix for an implantable bioartificial liver. J Biomater Sci Polym Ed 2005;16:1063-1080.
43. Lu HF, Lim WS, Wang J, Tang ZQ, Zhang PC, Leong KW, et al. Galactosylated PVDF membrane promotes hepatocyte attachment and functional maintenance. Biomaterials 2003;24:4893-4903.
44. De Bartolo L, Morelli S, Rende M, Gordano A, Drioli E. New modified polyetheretherketone membrane for liver cell culture in biohybrid systems: adhesion and specific functions of isolated hepatocytes. Biomaterials 2004;25: 3621-3629.
45. Seo SJ, Choi YJ, Akaike T, Higuchi A, Cho CS. Alginate/galactosylated chitosan/heparin scaffold as a new synthetic extracellular matrix for hepatocytes. Tissue Eng 2006;12: 33-44.
46. Matsumoto K, Nakamura T. Heparin functions as a hepatotrophic factor by inducing production of hepatocyte growth factor. Biochem Biophys Res Commun 1996;227: 455-461.
47. Cho CS, Seo SJ, Park IK, Kim SH, Kim TH, Hoshiba T, et al. Galactose-carrying polymers as extracellular matrices for liver tissue engineering. Biomaterials 2006;27:576-585.
48. Haldankar R, Li D, Saremi Z, Baikalov C, Deshpande R. Serum-free suspension large-scale transient transfection of CHO cells in WAVE bioreactors. Mol Biotechnol 2006;34: 191-199.
49. Weber W, Weber E, Geisse S, Memmert K. Optimisation of protein expression and establishment of the Wave Bioreactor for Baculovirus/ insect cell culture. Cytotechnology 2002;38: 77-85.
50. Tang YJ, Ohashi R, Hamel JF. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system. Biotechnol Prog 2007;23:255-264.